Crystal structure of the putative cell-wall lipoglycan biosynthesis protein LmcA from Mycobacterium smegmatis
- PMID: 35362472
- PMCID: PMC8972800
- DOI: 10.1107/S2059798322001772
Crystal structure of the putative cell-wall lipoglycan biosynthesis protein LmcA from Mycobacterium smegmatis
Abstract
The bacterial genus Mycobacterium includes important pathogens, most notably M. tuberculosis, which infects one-quarter of the entire human population, resulting in around 1.4 million deaths from tuberculosis each year. Mycobacteria, and the closely related corynebacteria, synthesize a class of abundant glycolipids, the phosphatidyl-myo-inositol mannosides (PIMs). PIMs serve as membrane anchors for hyperglycosylated species, lipomannan (LM) and lipoarabinomannan (LAM), which are surface-exposed and modulate the host immune response. Previously, in studies using the model species Corynebacterium glutamicum, NCgl2760 was identified as a novel membrane protein that is required for the synthesis of full-length LM and LAM. Here, the first crystal structure of its ortholog in Mycobacterium smegmatis, MSMEG_0317, is reported at 1.8 Å resolution. The structure revealed an elongated β-barrel fold enclosing two distinct cavities and one α-helix extending away from the β-barrel core, resembling a `cone with a flake' arrangement. Through xenon derivatization and structural comparison with AlphaFold2-derived predictions of the M. tuberculosis homolog Rv0227c, structural elements were identified that may undergo conformational changes to switch from `closed' to `open' conformations, allowing cavity access. An AlphaFold2-derived NCgl2760 model predicted a smaller β-barrel core with an enclosed central cavity, suggesting that all three proteins, which were collectively termed LmcA, may have a common mechanism of ligand binding through these cavities. These findings provide new structural insights into the biosynthetic pathway for a family of surface lipoglycans with important roles in mycobacterial pathogenesis.
Keywords: MSMEG_0317; Mycobacterium smegmatis; Mycobacterium tuberculosis; lipoarabinomannan; lipomannan.
open access.
Figures
Similar articles
-
Identification of a Membrane Protein Required for Lipomannan Maturation and Lipoarabinomannan Synthesis in Corynebacterineae.J Biol Chem. 2017 Mar 24;292(12):4976-4986. doi: 10.1074/jbc.M116.772202. Epub 2017 Feb 6. J Biol Chem. 2017. PMID: 28167532 Free PMC article.
-
Identification of a novel alpha(1-->6) mannopyranosyltransferase MptB from Corynebacterium glutamicum by deletion of a conserved gene, NCgl1505, affords a lipomannan- and lipoarabinomannan-deficient mutant.Mol Microbiol. 2008 Jun;68(6):1595-613. doi: 10.1111/j.1365-2958.2008.06265.x. Epub 2008 Apr 28. Mol Microbiol. 2008. PMID: 18452585 Free PMC article.
-
Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis.mBio. 2013 Feb 19;4(1):e00472-12. doi: 10.1128/mBio.00472-12. mBio. 2013. PMID: 23422411 Free PMC article.
-
Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria.J Biol Chem. 2010 Oct 29;285(44):33577-83. doi: 10.1074/jbc.R110.168328. Epub 2010 Aug 27. J Biol Chem. 2010. PMID: 20801880 Free PMC article. Review.
-
Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.Tuberculosis (Edinb). 2016 Jan;96:120-30. doi: 10.1016/j.tube.2015.09.005. Epub 2015 Oct 28. Tuberculosis (Edinb). 2016. PMID: 26586646 Review.
Cited by
-
AlphaFold2 and its applications in the fields of biology and medicine.Signal Transduct Target Ther. 2023 Mar 14;8(1):115. doi: 10.1038/s41392-023-01381-z. Signal Transduct Target Ther. 2023. PMID: 36918529 Free PMC article. Review.
-
An essential periplasmic protein coordinates lipid trafficking and is required for asymmetric polar growth in mycobacteria.Elife. 2022 Nov 8;11:e80395. doi: 10.7554/eLife.80395. Elife. 2022. PMID: 36346214 Free PMC article.
References
-
- Brennan, P. J. & Nikaido, H. (1995). Annu. Rev. Biochem. 64, 29–63. - PubMed
-
- Bricogne, G., Blanc, E., Brandl, M., Flensburg, C., Keller, P., Paciorek, W., Roversi, P., Sharff, A., Smart, O. S., Vonrhein, C. & Womack, T. O. (2017). BUSTER. Global Phasing Ltd, Cambridge, United Kingdom.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
